Nestle has agreed to sell its mainstream vitamins, minerals and supplements business to Boston-based private-equity firm Yellow Wood Partners for $1 billion. The portfolio includes Nature’s Bounty, Osteo Bi-Flex, Ester-C, Gard, Nuun, Puritan’s Pride and Sisu, along with Nestle’s U.S. private-label supplements business and related manufacturing, packaging, warehousing and distribution facilities. The assets generated approximately $1.2 billion in sales in 2025, primarily in the United States, with distribution also in Canada, China and other markets. The transaction remains subject to regulatory approvals and is expected to close in the first half of 2027. CEO Philipp Navratil described the divestiture as part of Nestle’s strategic portfolio transformation, while saying the company will retain premium brands including Solgar and Pure Encapsulations. The sale is part of a broader restructuring focused on coffee, pet care, nutrition, and food and snacks, alongside a target of at least CHF 2.5 billion in cost savings by the end of 2027.